SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy shares are experiencing significant volatility as investors weigh the company's long-term potential in powering data centers against broader concerns over data center project moratoriums and energy demands. The community remains divided, with some traders viewing the recent price dips as buying opportunities based on upcoming earnings and potential contract developments, while others warn of ongoing manipulation and negative sector sentiment.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell shares are trending following a second-quarter financial report that exceeded market expectations across revenue and earnings, driven by surging demand for AI-optimized servers. While retail investors debate whether the significant revenue growth and raised annual outlook justify current valuations or face long-term margin pressure, sentiment remains polarized between enthusiasm for the company's AI infrastructure backlog and caution over potential market volatility.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as traders debate its recent price decline, with many expressing frustration over persistent weakness and the stock's failure to maintain momentum. While some investors remain bullish on the long-term fundamentals and view the current dip as a buying opportunity, others are comparing the stock unfavorably to competitors like Robinhood and questioning the company's lack of immediate catalysts.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as traders react to rising Treasury yields, escalating geopolitical tensions in the Middle East, and increasing oil prices, which have triggered broader market concerns and intensified debates over the sustainability of AI-related valuations. While bulls point to resilient earnings from companies like Dell and potential for intraday technical bounces, bears cite persistent macroeconomic headwinds and the risk of a market correction.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are trending lower as investors weigh escalating geopolitical tensions in the Middle East against rising bond yields and inflation concerns. While some traders continue to focus on AI-driven momentum, sentiment has soured as oil prices surge and broader market uncertainty persists.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology shares are experiencing significant volatility following a fiscal first-quarter earnings report that featured a revenue beat but sparked investor concerns over margin compression, rising operating expenses, and a cooling pace of growth. While some traders view the resulting sell-off as an attractive buying opportunity based on the company's long-term AI connectivity outlook, others are cautious due to skinnier-than-expected guidance and broader macroeconomic headwinds.

GitLab, Inc. engages in the intelligent development, security, and operations (DevSecOps) platform for software innovation. It enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab shares are receiving attention following an expanded partnership with Google Cloud, which integrates GitLab's agentic AI platform with Vertex AI. While some traders view this as a potential catalyst for recovery from recent lows, others remain cautious, citing broader weakness in the software sector and ongoing concerns regarding AI's impact on business models.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares experienced high volatility following a fiscal Q2 earnings report that featured revenue and earnings beats alongside an updated full-year forecast. While some traders were encouraged by the growth, the shares faced pressure as investors focused on Atlas revenue growth missing higher-end expectations and a sequential moderation in forward guidance.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending amid rising oil prices driven by escalating geopolitical tensions in the Middle East following fresh U.S. military strikes on Iranian targets. Traders remain divided on the outlook for the energy sector, with some highlighting supply constraints and inflation concerns while others speculate that recent supply agreements may eventually pressure prices downward.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

ALMS is trending following the release of positive Phase 3 clinical trial results for its psoriasis treatment, envudeucitinib, which met all primary and secondary endpoints. While many traders are celebrating the 'best-in-class' data and optimistic price target revisions from analysts, a portion of the community remains cautious, citing the potential for share dilution through future equity offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Talphera (TLPH) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update PR Newswire SAN MATEO, Calif., Aug. 12, 2026 NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be...

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026 Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026 PR Newswire SAN MATEO, Calif., Aug. 5, 2026 SAN MATEO, Calif., Aug. 5, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH...

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026 Talphera to Host First Quarter Financial Results and Corporate Update Call and...

Talphera (NASDAQ:TLPH) CEO Acquires $125,852.90 in Stock

Talphera, Inc. (NASDAQ:TLPH - Get Free Report) CEO Vincent Angotti purchased 213,310 shares of the firm's stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average price of $0.59 per share, with a total value of $125,852.90. Following the purchase, the chief...

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 PR Newswire SAN MATEO, Calif., March 25...

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate...

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 Talphera to Host Virtual Investor & Analyst Event to...

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial PR Newswire SAN MATEO...

Reported GAAP EPS of -$0.06 up 40.00% YoY

Talphera reported a wider net loss and increased operating expenses for the second quarter of 2026, while facing ongoing regulatory and clinical development risks for its lead product candidate, Niyad.

Talphera achieved 75% enrollment in its NEPHRO CRRT study, benefited from favorable draft 2026 KDIGO guidelines for nafamostat, and identified a 21% increase in projected U.S. CRRT procedures by 2027.

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes Nafamostat, LTX-608, and Niyad. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Talphera Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.05	--	--	N/A
Q2 '26	-$0.06	-$0.06	4.00%	BEAT
Q1 '26	-$0.07	-$0.04	40.00%	BEAT
Q4 '25	-$0.08	-$0.06	20.00%	BEAT
Q3 '25	-$0.12	-$0.11	12.00%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings